open access

Vol 14, No 5 (2018)
Other materials agreed with the Editors
Published online: 2019-02-15
Get Citation

Current literature review

Maciej Kawecki
DOI: 10.5603/OCP.2018.0038
·
Oncol Clin Pract 2018;14(5):290-294.

open access

Vol 14, No 5 (2018)
CURRENT LITERATURE REVIEW
Published online: 2019-02-15

Abstract

xxx

Abstract

xxx
Get Citation
About this article
Title

Current literature review

Journal

Oncology in Clinical Practice

Issue

Vol 14, No 5 (2018)

Article type

Other materials agreed with the Editors

Pages

290-294

Published online

2019-02-15

DOI

10.5603/OCP.2018.0038

Bibliographic record

Oncol Clin Pract 2018;14(5):290-294.

Authors

Maciej Kawecki

References (5)
  1. Horn L, Mansfield AS, Szczęsna A, et al. IMpower133 Study Group. First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer. N Engl J Med. 2018 [Epub ahead of print].
  2. Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma. N Engl J Med. 2018; 379(1): 54–63.
  3. Smith M, Saad F, Chowdhury S, et al. Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer. New England Journal of Medicine. 2018; 378(15): 1408–1418.
  4. Hussain M, Fizazi K, Saad F, et al. Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer. N Engl J Med. 2018; 378(26): 2465–2474.
  5. Litton JK, Rugo HS, Ettl J, et al. Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation. N Engl J Med. 2018; 379(8): 753–763.

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Wydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl